ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

ClinicalTrials.gov ID: NCT06563479

Public ClinicalTrials.gov record NCT06563479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized and Double-blinded Trial of De-escalated Radiation in FMISO PET-selected Good Risk Versus Standard of Care Radiation in Unselected HPV Positive Oropharyngeal Cancer

Study identification

NCT ID
NCT06563479
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
291 participants

Conditions and interventions

Interventions

  • Assessments Other
  • Chemoradiation Combination Product
  • FMISO-PET Scan Diagnostic Test

Other · Combination Product · Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2024
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027
Last update posted
Apr 22, 2026

2024 – 2027

United States locations

U.S. sites
9
U.S. states
4
U.S. cities
9
Facility City State ZIP Site status
Hartford Healthcare (Data Collection Only) Hartford Connecticut 06102 Recruiting
Baptist Alliance MCI (Data Collection Only) Miami Florida 33143 Recruiting
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey 07920 Recruiting
Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown New Jersey 07748 Recruiting
Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey 07645 Recruiting
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack New York 11725 Recruiting
Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York 10604 Recruiting
Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York New York 10065 Recruiting
Memorial Sloan Kettering Nassau (Limited Protocol Activities) Uniondale New York 11553 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06563479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06563479 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →